TrialThe oncologist2019

Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial.

Astrid Lipplaa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.